19-50289926-C-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001145809.2(MYH14):​c.4965+278C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.669 in 151,810 control chromosomes in the GnomAD database, including 35,607 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.67 ( 35607 hom., cov: 29)

Consequence

MYH14
NM_001145809.2 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.424

Publications

8 publications found
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
MYH14 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 4A
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 19-50289926-C-G is Benign according to our data. Variant chr19-50289926-C-G is described in ClinVar as Benign. ClinVar VariationId is 1239931.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.897 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001145809.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH14
NM_001145809.2
MANE Select
c.4965+278C>G
intron
N/ANP_001139281.1Q7Z406-2
MYH14
NM_001077186.2
c.4866+278C>G
intron
N/ANP_001070654.1Q7Z406-6
MYH14
NM_024729.4
c.4842+278C>G
intron
N/ANP_079005.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH14
ENST00000642316.2
MANE Select
c.4965+278C>G
intron
N/AENSP00000493594.1Q7Z406-2
MYH14
ENST00000425460.6
TSL:5
c.4866+278C>G
intron
N/AENSP00000407879.1Q7Z406-6
MYH14
ENST00000598205.5
TSL:5
c.4866+278C>G
intron
N/AENSP00000472543.1Q7Z406-6

Frequencies

GnomAD3 genomes
AF:
0.669
AC:
101441
AN:
151692
Hom.:
35582
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.441
Gnomad AMI
AF:
0.644
Gnomad AMR
AF:
0.772
Gnomad ASJ
AF:
0.769
Gnomad EAS
AF:
0.918
Gnomad SAS
AF:
0.779
Gnomad FIN
AF:
0.761
Gnomad MID
AF:
0.737
Gnomad NFE
AF:
0.737
Gnomad OTH
AF:
0.685
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.669
AC:
101509
AN:
151810
Hom.:
35607
Cov.:
29
AF XY:
0.676
AC XY:
50161
AN XY:
74188
show subpopulations
African (AFR)
AF:
0.441
AC:
18213
AN:
41338
American (AMR)
AF:
0.773
AC:
11798
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.769
AC:
2669
AN:
3470
East Asian (EAS)
AF:
0.919
AC:
4720
AN:
5138
South Asian (SAS)
AF:
0.779
AC:
3754
AN:
4816
European-Finnish (FIN)
AF:
0.761
AC:
8030
AN:
10556
Middle Eastern (MID)
AF:
0.731
AC:
215
AN:
294
European-Non Finnish (NFE)
AF:
0.737
AC:
50076
AN:
67918
Other (OTH)
AF:
0.688
AC:
1449
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1537
3073
4610
6146
7683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.701
Hom.:
4797
Bravo
AF:
0.660
Asia WGS
AF:
0.833
AC:
2896
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
4.9
DANN
Benign
0.66
PhyloP100
0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs588035; hg19: chr19-50793183; API